FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074039643> ?p ?o ?g. }

• W2074039643 abstract "You have accessJournal of UrologyUrodynamics/Incontinence/Female Urology: Incontinence—Evaluation & Therapy1 Apr 20111343 TREATMENT INTERVAL FREQUENCY OF PERCUTANEOUS TIBIAL NERVE STIMULATION: PRELIMINARY RESULTS FROM THE STEP STUDY Scott A. MacDiarmid, Kenneth M. Peters, Donna J. Carrico, and Leslie S. Wooldridge Scott A. MacDiarmidScott A. MacDiarmid Greensboro, NC More articles by this author , Kenneth M. PetersKenneth M. Peters Royal Oak, MI More articles by this author , Donna J. CarricoDonna J. Carrico Royal Oak, MI More articles by this author , and Leslie S. WooldridgeLeslie S. Wooldridge Muskegon, MI More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2011.02.1164AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The Sustained Therapeutic Effects of Percutaneous Tibial Nerve Stimulation (STEP) Study is was to evaluate long term therapy effectiveness with percutaneous tibial nerve stimulation (PTNS) for overactive bladder symptoms (OAB). The objective of this review is to evaluate the treatment interval frequency though 12 months of sustained therapy. METHODS Subjects participating in STEP met the primary endpoint of success after 12 weekly PTNS treatments were invited to participate in the long term study. Subjects were prescribed an initial tapering protocol of PTNS for 3 months and then received ongoing therapy at an individualized frequency as determined by the investigator and subject to maintain sustained improvement in the subject's OAB symptoms. Questionnaires were completed every 3 months and voiding diaries were completed every 6 months from initial treatment baseline. RESULTS Of the 60 subjects eligible to continue, 87% (52/60) enrolled in the STEP Study. Of the 52 subjects, 52 completed 6 months, 49 continued through 9 months and 46 continued to 12 months. The mean number of days between treatments and the mean number of treatments per month by follow up interval is outlined in the table below. Voiding diary parameters at 6 and 12 months were significant for improvement compared to baseline for frequency, incontinence episodes, nighttime voids and moderate to severe urgency episodes. CONCLUSIONS Sustained efficacy of PTNS was demonstrated over 12 months following initial success at 12 weeks. Treatment interval frequency results in this study closely mimic those of 12 month outcomes reported in similar trials. © 2011 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 185Issue 4SApril 2011Page: e537 Peer Review Report Advertisement Copyright & Permissions© 2011 by American Urological Association Education and Research, Inc.MetricsAuthor Information Scott A. MacDiarmid Greensboro, NC More articles by this author Kenneth M. Peters Royal Oak, MI More articles by this author Donna J. Carrico Royal Oak, MI More articles by this author Leslie S. Wooldridge Muskegon, MI More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ..." @default.
• W2074039643 created "2016-06-24" @default.
• W2074039643 creator A5000491178 @default.
• W2074039643 creator A5047579820 @default.
• W2074039643 creator A5061105227 @default.
• W2074039643 creator A5075986926 @default.
• W2074039643 date "2011-04-01" @default.
• W2074039643 modified "2023-09-24" @default.
• W2074039643 title "1343 TREATMENT INTERVAL FREQUENCY OF PERCUTANEOUS TIBIAL NERVE STIMULATION: PRELIMINARY RESULTS FROM THE STEP STUDY" @default.
• W2074039643 doi "https://doi.org/10.1016/j.juro.2011.02.1164" @default.
• W2074039643 hasPublicationYear "2011" @default.
• W2074039643 type Work @default.
• W2074039643 sameAs 2074039643 @default.
• W2074039643 citedByCount "0" @default.
• W2074039643 crossrefType "journal-article" @default.
• W2074039643 hasAuthorship W2074039643A5000491178 @default.
• W2074039643 hasAuthorship W2074039643A5047579820 @default.
• W2074039643 hasAuthorship W2074039643A5061105227 @default.
• W2074039643 hasAuthorship W2074039643A5075986926 @default.
• W2074039643 hasConcept C126322002 @default.
• W2074039643 hasConcept C141071460 @default.
• W2074039643 hasConcept C142724271 @default.
• W2074039643 hasConcept C168563851 @default.
• W2074039643 hasConcept C1862650 @default.
• W2074039643 hasConcept C203092338 @default.
• W2074039643 hasConcept C204787440 @default.
• W2074039643 hasConcept C24998067 @default.
• W2074039643 hasConcept C2776825438 @default.
• W2074039643 hasConcept C2778941218 @default.
• W2074039643 hasConcept C2780813298 @default.
• W2074039643 hasConcept C44249647 @default.
• W2074039643 hasConcept C71924100 @default.
• W2074039643 hasConceptScore W2074039643C126322002 @default.
• W2074039643 hasConceptScore W2074039643C141071460 @default.
• W2074039643 hasConceptScore W2074039643C142724271 @default.
• W2074039643 hasConceptScore W2074039643C168563851 @default.
• W2074039643 hasConceptScore W2074039643C1862650 @default.
• W2074039643 hasConceptScore W2074039643C203092338 @default.
• W2074039643 hasConceptScore W2074039643C204787440 @default.
• W2074039643 hasConceptScore W2074039643C24998067 @default.
• W2074039643 hasConceptScore W2074039643C2776825438 @default.
• W2074039643 hasConceptScore W2074039643C2778941218 @default.
• W2074039643 hasConceptScore W2074039643C2780813298 @default.
• W2074039643 hasConceptScore W2074039643C44249647 @default.
• W2074039643 hasConceptScore W2074039643C71924100 @default.
• W2074039643 hasIssue "4S" @default.
• W2074039643 hasLocation W20740396431 @default.
• W2074039643 hasOpenAccess W2074039643 @default.
• W2074039643 hasPrimaryLocation W20740396431 @default.
• W2074039643 hasRelatedWork W1592648698 @default.
• W2074039643 hasRelatedWork W1965240443 @default.
• W2074039643 hasRelatedWork W1968895160 @default.
• W2074039643 hasRelatedWork W2024863897 @default.
• W2074039643 hasRelatedWork W2069266955 @default.
• W2074039643 hasRelatedWork W2105588889 @default.
• W2074039643 hasRelatedWork W2135539529 @default.
• W2074039643 hasRelatedWork W2144368456 @default.
• W2074039643 hasRelatedWork W2766026571 @default.
• W2074039643 hasRelatedWork W2796644579 @default.
• W2074039643 hasRelatedWork W2797201471 @default.
• W2074039643 hasRelatedWork W2895051169 @default.
• W2074039643 hasRelatedWork W2895582286 @default.
• W2074039643 hasRelatedWork W2901442310 @default.
• W2074039643 hasRelatedWork W2905528065 @default.
• W2074039643 hasRelatedWork W2945397293 @default.
• W2074039643 hasRelatedWork W2969821690 @default.
• W2074039643 hasRelatedWork W2993748943 @default.
• W2074039643 hasRelatedWork W3092796492 @default.
• W2074039643 hasRelatedWork W3115447090 @default.
• W2074039643 hasVolume "185" @default.
• W2074039643 isParatext "false" @default.
• W2074039643 isRetracted "false" @default.
• W2074039643 magId "2074039643" @default.
• W2074039643 workType "article" @default.